Determination of NSI Regarding Bloodborne Pathogens Among Healthcare Workers at Tertiary Care, DIK

NCT ID: NCT07055100

Last Updated: 2025-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

280 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-17

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bloodborne pathogens (BBPs) are a significant occupational hazard for healthcare professionals, particularly those working in high-risk environments like emergency departments. This study aims to assess the prevalence of bloodborne pathogens, including Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV), among emergency department staff of District Head Quarter (DHQ) Hospital, Dera Ismail Khan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Needle Stick Injuries

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Needle stick injuries

A descriptive cross-sectional study design will be employed, and data will be collected from all staff working in the trauma center through census sampling. A structured questionnaire will capture demographic data, occupational risk factors, and KAP regarding bloodborne pathogens. Blood samples will be collected to screen for HBV, HCV, and HIV infections.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthcare workers (doctors, nurses, technologists, paramedics, and support staff) working in a tertiary care hospital in Dera Ismail Khan.
* Staff members who have occupational exposure to blood and other body fluids.
* Individuals willing to participate in the study and provide informed consent.
* Participants available during the data collection period and conveniently accessible.

Exclusion Criteria

* Individuals not willing to participate in the study and provide informed consent.
* Participants and Staff members who have no exposure to blood and other body fluids.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Superior University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Muhammad Naveed Babur

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

DHQ Hospital

Dera Ismāīl Khān, Khyber Pakhtunkhwa, Pakistan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Pakistan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MSAHSW/Batch-Fall23/919

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hepatitis B Birth Dose for Newborns
NCT04870021 COMPLETED PHASE4